(Public, LON:IXI)   Watch this stock  
Find more results for Charles Lowther�
+1.00 (3.23%)
Jul 22 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 32.00 - 32.00
52 week 27.00 - 42.00
Open 31.00
Vol / Avg. 5,000.00/2,947.00
Mkt cap 8.20M*
P/E     -
Div/yield     -
EPS -0.08*
Shares 26.44M
Beta     -
Inst. own     -
Jun 7, 2016
Half Year 2016 IXICO PLC Earnings Release

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -66.86% -38.33%
Operating margin -72.20% -44.75%
EBITD margin - -28.19%
Return on average assets -36.92% -24.74%
Return on average equity -52.27% -36.62%
Employees 61 -
CDP Score - -


4th Floor, 15 Long Lane, Griffin Court
United Kingdom - Map
+44-20-37637499 (Phone)
+44-20-72092473 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


IXICO plc is engaged in the provision of clinical trials services to the pharmaceutical industry. The Company provides its technologies to those involved in researching and treating diseases, such as dementia. The Company's digital health technology consists of three product platforms, which include TrialTracker, Assessa and MyBrainBook. Its TrialTracker image data and query management platform serves its clinical trials business. TrialTracker is used in clinical trials run by IXICO and forms the framework for its medical device, Assessa. The Company's Assessa is its decision support tool for diagnosing dementia and Alzheimer's disease. Assessa is also used in other neurological disorders in which the measurement of hippocampal volume can be used, such as schizophrenia. Its MyBrainBook provides support to dementia patients post-diagnosis. MyBrainBook is a digital health hub delivering facilitated support to patients and their carers.

Officers and directors

Derek Hill Ph.D. Chief Executive Officer, Director
Susan Day Lowther Chief Financial Officer
Age: 55
Michelle Lax Vice President - Clinical Operations
Charles Spicer Vice President - Corporate Development, Director
Age: 48
Jane Whitrow Secretary
Andrew John McGlashan Richards Ph.D. Non-Executive Chairman of the Board
Maina Bhaman Non-Executive Director
John Bradshaw Non-Executive Director
Tim Sharpington Senior Non-Executive Independent Director